Apyx Medical Corp Stock Nasdaq
Equities
US03837C1062
Medical Equipment, Supplies & Distribution
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.6 USD | -74.11% | +14.44% | -4.63% |
05-09 | Transcript : Apyx Medical Corporation, Q1 2024 Earnings Call, May 09, 2024 | |
05-09 | Stavros Vizirgianakis Enters into Letter Agreement with Apyx Medical | CI |
Sales 2024 * | 50.01M 68.05M | Sales 2025 * | 54.67M 74.39M | Capitalization | 53.01M 72.12M |
---|---|---|---|---|---|
Net income 2024 * | -26M -35.38M | Net income 2025 * | -24M -32.66M | EV / Sales 2024 * | 1.06 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.97 x |
P/E ratio 2024 * |
-2.04
x | P/E ratio 2025 * |
-2.26
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.08% |
Latest transcript on Apyx Medical Corp
Managers | Title | Age | Since |
---|---|---|---|
Charles Goodwin
CEO | Chief Executive Officer | 58 | 17-12-14 |
Matthew Hill
DFI | Director of Finance/CFO | 56 | 12-03 |
Kari Larson
CTO | Chief Tech/Sci/R&D Officer | - | 19-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lawrence Waldman
BRD | Director/Board Member | 77 | 11-03-14 |
Craig Swandal
BRD | Director/Board Member | 63 | 18-03-08 |
John Andres
BRD | Director/Board Member | 66 | 14-07-16 |
1st Jan change | Capi. | |
---|---|---|
-5.21% | 182B | |
+4.09% | 114B | |
-3.13% | 68.38B | |
+6.03% | 52.46B | |
+8.06% | 44.25B | |
+7.52% | 43.55B | |
+25.07% | 32.69B | |
+17.85% | 26.73B | |
-0.58% | 25.79B |